CVS Health Co. (NYSE:CVS) Shares Sold by Commerce Bank

Commerce Bank lessened its stake in CVS Health Co. (NYSE:CVSGet Rating) by 1.3% during the 1st quarter, HoldingsChannel.com reports. The fund owned 175,950 shares of the pharmacy operator’s stock after selling 2,353 shares during the period. Commerce Bank’s holdings in CVS Health were worth $17,807,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. West Bancorporation Inc. purchased a new stake in CVS Health in the 4th quarter valued at approximately $25,000. Macroview Investment Management LLC boosted its holdings in CVS Health by 128.3% in the 1st quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 136 shares in the last quarter. Claremont Financial Group Inc. purchased a new stake in CVS Health in the 4th quarter valued at approximately $26,000. Stuart Chaussee & Associates Inc. boosted its holdings in CVS Health by 123.0% in the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 171 shares in the last quarter. Finally, Capital Advisors Ltd. LLC boosted its holdings in CVS Health by 125.7% in the 4th quarter. Capital Advisors Ltd. LLC now owns 316 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 176 shares in the last quarter. Hedge funds and other institutional investors own 78.00% of the company’s stock.

CVS Health Trading Down 0.3 %

Shares of CVS opened at $102.00 on Tuesday. The stock has a fifty day moving average of $94.44 and a two-hundred day moving average of $99.89. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.65 and a current ratio of 0.91. The company has a market capitalization of $133.91 billion, a PE ratio of 16.59, a price-to-earnings-growth ratio of 1.56 and a beta of 0.75. CVS Health Co. has a fifty-two week low of $80.82 and a fifty-two week high of $111.25.

CVS Health (NYSE:CVSGet Rating) last issued its quarterly earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share for the quarter, beating the consensus estimate of $2.16 by $0.24. The company had revenue of $80.64 billion during the quarter, compared to the consensus estimate of $76.38 billion. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. CVS Health’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.42 EPS. As a group, analysts forecast that CVS Health Co. will post 8.54 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Friday, July 22nd were issued a dividend of $0.55 per share. The ex-dividend date was Thursday, July 21st. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.16%. CVS Health’s payout ratio is 35.77%.

Insider Transactions at CVS Health

In other news, EVP Thomas M. Moriarty sold 138,654 shares of the company’s stock in a transaction on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the sale, the executive vice president now directly owns 626,273 shares in the company, valued at approximately $59,495,935. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Thomas M. Moriarty sold 138,654 shares of the company’s stock in a transaction on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the sale, the executive vice president now directly owns 626,273 shares in the company, valued at approximately $59,495,935. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Alan Lotvin sold 22,541 shares of the company’s stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total value of $2,344,264.00. Following the sale, the executive vice president now owns 109,183 shares of the company’s stock, valued at $11,355,032. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CVS shares. Sanford C. Bernstein lowered CVS Health from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $122.00 to $112.00 in a research note on Thursday, May 26th. Loop Capital started coverage on CVS Health in a research note on Thursday, June 16th. They set a “buy” rating and a $120.00 price target on the stock. UBS Group boosted their price target on CVS Health from $118.00 to $127.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Deutsche Bank Aktiengesellschaft boosted their price target on CVS Health from $113.00 to $120.00 in a research note on Thursday, August 4th. Finally, Credit Suisse Group boosted their price target on CVS Health from $113.00 to $117.00 and gave the stock an “outperform” rating in a research note on Monday. Four analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $116.76.

About CVS Health

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Featured Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.